Macroaxis considers Natus Medical not too risky given 2 months investment horizon. Natus Medical Incorp has Sharpe Ratio of 0.2352 which conveys that Natus Medical Incorp had 0.2352% of return per unit of risk over the last 2 months. Our philosophy towards estimating volatility of a stock is to use all available market data together with company specific technical indicators that cannot be diversified away. We have found twenty-eight technical indicators for Natus Medical which you can use to evaluate future volatility of the firm. Please exercise Natus Medical Incorporated Downside Deviation of 1.71, Mean Deviation of 1.24 and Risk Adjusted Performance of 0.3925 to check out if our risk estimates are consistent with your expectations.
|Time Horizon||30 Days Login to change|
Natus Medical Market Sensitivity
|As returns on market increase, Natus Medical returns are expected to increase less than the market. However during bear market, the loss on holding Natus Medical will be expected to be smaller as well.2 Months Beta |Analyze Natus Medical Incorp Demand TrendCheck current 30 days Natus Medical correlation with market (DOW)|
β = 0.0397
Natus Medical Incorp Technical Analysis
Projected Return Density Against MarketGiven the investment horizon of 30 days, Natus Medical has beta of 0.0397 . This suggests as returns on market go up, Natus Medical average returns are expected to increase less than the benchmark. However during bear market, the loss on holding Natus Medical Incorporated will be expected to be much smaller as well. Moreover, Natus Medical Incorporated has an alpha of 0.379 implying that it can potentially generate 0.379% excess return over DOW after adjusting for the inherited market risk (beta).
Predicted Return Density